Trial Profile
A retrospective inception cohort study comparing the effectiveness of treatment between first-generation antipsychotic long-acting injectables and risperidone long-acting injectable in patients with schizophrenia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Feb 2016
Price :
$35
*
At a glance
- Drugs Risperidone (Primary) ; Flupentixol; Fluphenazine; Haloperidol; Perphenazine; Zuclopenthixol
- Indications Schizophrenia
- Focus Therapeutic Use
- 26 Feb 2016 New trial record